Vyalev (foslevodopa foscarbidopa)

pCPA File Number: 22403

Negotiation Status:

Concluded with an LOI

Indication(s):

For the treatment of motor fluctuations in patients with advanced levodopa-responsive Parkinson's disease.

Sponsor/Manufacturer:

AbbVie Corporation

CADTH Project Number:

SR0768

pCPA Engagement Letter Issued:

2024-02-22

Negotiation Process Concluded:

2024-04-26